Eris Lifesciences
Signals mentioning Eris Lifesciences
- India pharma market grows 13% in August as GLP-1 therapies accelerate
- India’s GLP-1 drug market could reach Rs 15,700 crore by FY32, led by generics
- Motilal Oswal retains Radico Khaitan as preferred buy in Q1 FY27 review
- BSE admits ESOP shares for Vishal Mega Mart, Nykaa, Ather effective May 20